Short Interval Infield Sarcoma Development following Resection of Glioblastoma and Adjuvant Radiotherapy and Temozolomide
Background. The development of 2 unassociated brain cancers in the same patient is a rare occurrence. Secondary cancers are generally thought to develop as an oncogenic consequence of the radiation therapy delivered to treat the primary cancers, always requiring a significant time interval between r...
Saved in:
| Main Authors: | Fahad E. Alotaibi, Kevin Petrecca |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Case Reports in Medicine |
| Online Access: | http://dx.doi.org/10.1155/2013/591272 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Kaposi’s sarcoma occurring in a glioblastoma multiforme on temozolomide
by: Jiong-Huang Lim, et al.
Published: (2025-01-01) -
Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors
by: Supriya Mallick, et al.
Published: (2015-01-01) -
Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide
by: Erkan Topkan, et al.
Published: (2020-01-01) -
The role of temozolomide as adjuvant therapy in glioblastoma management: a systematic review and meta-analysis.
by: Made Agus Mahendra Inggas, et al.
Published: (2025-03-01) -
Adjuvant radiotherapy for pleomorphic dermal sarcoma
by: D. Helbig, et al.
Published: (2024-12-01)